Form4insider filings, from the source

SEC Form 4 · accession 0001209191-18-053539

Entasis Therapeutics Holdings Inc. · ETTX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
James Healy
10% Owner
Anand Mehra
10% Owner
Period of report
Sep 28, 2018
Accepted (ET)
Oct 2, 2018 · 9:41 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001724344

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Sep 28, 2018C359,267—A359,267D
Common StockF1,F3,F2Sep 28, 2018C458,425—A842,454D
Common StockF2Sep 28, 2018P337,724$15.00A1,180,178D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Series B-1 Tranche A Convertible Preferred StockF2,F1—Sep 28, 2018C7,446,904D——Common Stock359,2670D
Series B-1 Tranche B Convertible Preferred StockF2,F1—Sep 28, 2018C9,502,249D——Common Stock458,4250D

Explanation of responses